Sanofi India Ltd (SANOFI) โ Insider Trading | 18 September 2026
Sanofi Healthcare India Private Limited agreed to acquire up to 3.5 million shares of Sanofi India Ltd from Hoechst GmbH, representing up to 15.20% of the paid-up equity share capital. The transaction is an inter-se transfer among promoter group members and is exempt from open offer under SEBI SAST Regulation 10(1)(a)(iii). The shares will be purchased at a price not exceeding the limits specified in the Takeover Regulations, with the acquisition price capped at 25% above the 60-day volume-weighted average price of Rs. 3,228.06 per share. Post-acquisition, Sanofi Healthcare India Private Limited will hold 3.5 million shares (15.20% stake), while Hoechst GmbH will reduce its holding from 13.9 million shares (60.38%) to 10.4 million shares (45.18%).
About Sanofi India Ltd (SANOFI)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when SANOFI files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track SANOFI โ Free๐ก Ask AI about this filing
๐ More SANOFI filings
- ๐ด Insider Trading โ 28 September 2026Sanofi Healthcare India Private Limited acquired 3,500,000 shares representing 15.20% of Sanofi Indi...
- ๐ด Insider Trading โ 28 September 2026Sanofi India disclosed an insider trading transaction where Sanofi Healthcare India Private Limited,...
- ๐ด Insider Trading โ 28 September 2026Sanofi India disclosed an insider transaction where promoter Hoechst GmbH transferred shares to Sano...
- Announcement โ 25 September 2026Sanofi India announced that its trading window will close on October 1, 2026, to comply with SEBI in...
- ๐ด Insider Trading โ 25 September 2026Sanofi Healthcare India Private Limited, part of the promoter group, acquired 3,500,000 shares repre...
๐ฅ Also filed on 18 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when SANOFI files new disclosures
Track SANOFI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SANOFI โ FreeFree account ยท 2 AI queries/day